• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

3.420 -0.300 (-8.06%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,917,480
Open 3.640
Bid (Size) 3.430 (200)
Ask (Size) 3.440 (13,400)
Prev. Close 3.720
Today's Range 3.380 - 3.700
52wk Range 2.980 - 9.740
Shares Outstanding 168,425,907
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
Today 10:22 EST
Ark Invest added to three positions that are well below last year's highs. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
NVIDIA’s 13F Bombshell: A New AI Power Trio Emerges ↗
February 19, 2026
Via MarketBeat
Topics Artificial Intelligence

Performance

YTD
-18.6%
-18.6%
1 Month
-27.7%
-27.7%
3 Month
-21.0%
-21.0%
6 Month
-29.2%
-29.2%
1 Year
-62.0%
-62.0%

More News

Read More
News headline image
Recursion Pharmaceuticals Stock Drops: What's Behind It? ↗
February 18, 2026
Via Benzinga
News headline image
Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25
February 18, 2026
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot
February 17, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
February 12, 2026
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
This $4 Stock Could Be Your Ticket to Millionaire Status ↗
February 07, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Harvard’s PopEVE AI Cracks the Code of Rare Diseases: Ending the ‘Diagnostic Odyssey’ for Millions
February 06, 2026
Via TokenRing AI
Topics Artificial Intelligence
News headline image
AI’s ‘Penicillin Moment’: How Generative Models Are Slashing Decades of Antibiotic Research into Months
February 06, 2026
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Forget 2025: These 2 Growth Stocks Could Soar in 2026 ↗
January 29, 2026
Via The Motley Fool
News headline image
Can This Beaten-Down AI Stock Bounce Back in 2026? ↗
January 28, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
2 AI Stocks to Buy in 2026, and 1 to Avoid ↗
January 16, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Beyond the Protein: How AlphaFold 3 Redefined the Blueprint of Life and Accelerated the Drug Discovery Revolution
January 12, 2026
Via TokenRing AI
Topics Artificial Intelligence
News headline image
From Silicon to Syringes: Nvidia’s AI Dominance Solidified Through Landmark Eli Lilly Alliance
January 12, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference
January 06, 2026
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
The $3 Billion Bet: How Isomorphic Labs is Rewriting the Rules of Drug Discovery with Eli Lilly and Novartis
January 01, 2026
Via TokenRing AI
Topics Artificial Intelligence
News headline image
The Great Unlocking: How AlphaFold 3’s Open-Source Pivot Sparked a New Era of Drug Discovery
January 01, 2026
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy. ↗
January 01, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Cathie Wood’s Strategic Pivot: Ark Invest Trims Tesla Holdings to Fuel AI and Crypto Bets Ahead of 2026
December 25, 2025
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Myseum (NASDAQ: MYSE) Ignites “Picture Party,” a New Era in Social Media on All Apple (NASDAQ: AAPL) Devices Now! more stocks inside…
December 17, 2025
Via AB Newswire
Topics Artificial Intelligence
Why Recursion Pharmaceuticals Stock Vaulted 11% Higher on Wednesday ↗
December 17, 2025
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Recursion Pharmaceuticals Stock Is Soaring Today: Here's Why ↗
December 17, 2025
Via Benzinga
News headline image
Oracle, Hut 8, Processa Pharmaceuticals, Recursion Pharmaceuticals, Udemy: Stocks Making The Biggest Moves Today ↗
December 17, 2025
Via Stocktwits
Topics Artificial Intelligence ETFs Stocks
News headline image
Why Recursion Pharamaceuticals Topped the Market Today ↗
December 08, 2025
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
December 08, 2025
From Recursion Pharmaceuticals, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 3.420
When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 02/20/26 04:00 PM ET
What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 576.02M
How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Recursion Pharmaceuticals, Inc. - Class A Common Stock has 576M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap